This is a complex case involving a non-naturally occurring erythropoietin-glycoprotein product having a defined in vivo biological activity and having glycosylation which differs from that of human urinary...

This was a Paragraph IV certification case filed after Novopharm filed an ANDA to market a generic form of fenofibrate prior to expiration of the relevant...

The invention related to the isolation of the virus that caused “Mystery swine disease” (a.k.a Porcine Reproductive Respiratory Syndrome – PRRS). The claim was directed to growing and isolating a particular virus. The alleged infringement...